Molecular Biology and Biomarker Development of AKT Inhibition in Gastro-oesophageal Adenocarcinoma.
School of Medicine, Dentistry and Biomedical Sciences
- Location
- Belfast, United Kingdom
- Funding
- See university guidance
- Application deadline
- See university guidance
About the project
The Upper GI Translational Research group studies biomarkers and drug resistance mechanisms in cancers of the oesophagus, stomach and pancreas.
The group incorporates a comprehensive research programme of research laboratory, tissue and plasma biobanking and a clinical trials in order to translate scientific discoveries into clinical practice.
- Dr Richard Turkington: School of Medicine, Dentistry and Biomedical Sciences
Contact info
- View Academic Profile
- askmhls@qub.ac.uk
- +44 (0)28 9097 2756
Research Interests
Open to PhD applications in the field of
Make a PhD enquiry
- Laboratory based investigations of novel drugs and biomarkers
- Discovery of resistance mechanisms to therapy
- Innovative biomarker development using clinical samples
Public outreach & key achievements
- Oesophageal Patients’ Association Dr Turkington is a member of the Oesophageal Patient’s Association (OPA) Steering Committee and am an active participant in outreach and fundraising events for the OPA. The OPA is a patient support and fundraising group for patients with oesophageal cancer and their events are often attended by local MLA’s, providing opportunities to discuss research funding with local government.
- Friends of the Cancer centre Dr Turkington is also an active fundraiser for the Friends of the Cancer Centre
Research students
PhD Title | Molecular Biology and Biomarker Development of AKT Inhibition in Gastro-oesophageal Adenocarcinoma.
Country | Northern Ireland
PhD Title | Identification of Targetable Mediators of Resistance to Neo-Adjuvant Chemotherapy in Oesophageal Adenocarcinoma
Country | Malaysia
PhD Title | A Pathways-based Approach to Identify Determinants of Drug Resistance in Oesophageal Adenocarcinoma (OAC)
Country | Ireland
PhD Title | Identification of Novel Molecular Biomarkers Predictive of Benefit to Neo-adjuvant Chemotherapy in Oesophageal Adenocarcinoma
Country | Ireland
Discover More
- Faculty of Medicine, Health and Life Sciences
- School of Medicine, Dentistry and Biomedical Sciences